Answers are grounded in this paper and cite their sources.
Equity in access to pharmaceutical services is a critical component of resilient and inclusive health systems, particularly in low- and middle-income countries. Geographic disparities in pharmacy distribution can hinder progress toward universal health coverage and exacerbate health inequalities. Iran, with its diverse provinces and centralized health governance, offers a valuable case for equity assessment over time. We conducted a longitudinal national study evaluating pharmacy distribution equity across Iran’s 31 provinces from 2011 to 2024. Using population and pharmacy data from official government sources, we applied the Gini coefficient and Lorenz curve to measure geographic disparities at four time points (2011, 2016, 2021, and 2024). The national Gini coefficient decreased from 2011 to 2024, indicating substantial improvement in the equitable distribution of pharmacies. Provinces with historically low access showed the greatest relative gains, while metropolitan areas such as Tehran continued to exhibit disproportionately high pharmacy concentrations. Policy interventions—including the expansion of pharmacy education, decentralized license issuance, and emphasis on generic pharmaceutical production—were key drivers of this progress. Iran’s experience demonstrates that strategic, equity-focused health reforms can significantly reduce geographic disparities in pharmacy access, even within constrained resource environments. As a country-specific case, Iran exemplifies how low- and middle-income countries can design and implement integrated policy approaches to improve equitable service distribution. These findings have broader relevance for health policymakers in similar contexts, offering a replicable framework for measuring, addressing, and sustaining health service equity.
No takes yet. Share an insight, caveat, or question.
Hadi Hayati (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: